Page 65 - IMO-2-2

Innovative Medicines & Omics Open source bioinformatics tools in Africa

with potential therapeutics. MD simulations have had a costs associated with proprietary software, researchers can
particularly impactful impact on malaria and TB research access cutting-edge technology and conduct sophisticated
in Africa. Researchers in Uganda and Nigeria have used MD analyses without financial barriers. This democratization
68
simulations to study the PfATP6 protein, a key drug target of scientific tools enables greater participation in global
in Plasmodium falciparum, leading to the development research efforts and fosters innovation within the continent.
of more effective antimalarial drugs. Similarly, MD However, despite these advantages, several
64
simulations have been employed in South Africa to study challenges hinder the widespread adoption of open-
the M. tuberculosis DNA gyrase enzyme, a target for TB source bioinformatics tools in Africa. Limited internet
drugs, identifying compounds with improved binding access, scarce computational resources, and inadequate
affinity and reduced resistance. 65
62
local training programs present significant obstacles.
Binding free energy calculations using methods such Proprietary tools often come with dedicated support and
as molecular mechanics/Poisson–Boltzmann surface area user-friendly interfaces, which open-source alternatives
have enhanced the accuracy of drug-target interaction may lack. In addition, interoperability between different
predictions. In Kenya, binding free energy analysis has bioinformatics platforms remains a challenge. For example,
been used to evaluate HIV protease inhibitors, reducing tools such as PhyML and RAxML could provide greater
the time and cost associated with traditional drug insights if integrated seamlessly with disease-specific
66
screening methods. Similarly, in Ghana, this approach applications. Overcoming these limitations will require
68
has optimized the binding of dihydroartemisinin concerted efforts to enhance the usability and compatibility
derivatives to the PfATP6 protein, addressing the challenge of open-source tools.
of artemisinin resistance in malaria-endemic regions. 53
On a positive note, advancements in satellite internet,
Another key computational approach is ADMET such as Starlink, are reshaping the digital landscape by
analysis, which ensures that potential drug candidates providing reliable connectivity to remote areas. This
have favorable pharmacokinetic and safety profiles. Open- development allows researchers in rural regions to access
source tools like ADMETlab have been widely adopted in critical bioinformatics tools and participate in global
Africa for research on malaria, TB, and sickle cell anemia. research networks, thus bridging the digital divide.
69
ADMET analysis has been used in Tanzania to screen Expanding digital infrastructure will ensure equitable
natural compounds derived from local medicinal plants, access to bioinformatics resources across Africa.
identifying potential antimalarial and anti-TB agents.
54
Similarly, in Nigeria, ADMET analysis has helped evaluate Another pressing issue is the scarcity of African-specific
the safety and efficacy of hydroxyurea derivatives for sickle genomic data. While databases such as the PDB include
cell anemia treatment. 40 structures from African pathogens, more contributions
are needed, particularly for underrepresented diseases.
70
Genomic research in Africa has also benefited from Increasing African participation in global databases will
tools such as PLINK and MAFFT. PLINK has been significantly improve the quality and relevance of research
instrumental in genome-wide association studies and conducted on the continent. Addressing this gap requires
genetic data analysis, helping researchers in South Africa strategic data collection and curation investments to build
identify genetic variants associated with HIV resistance. comprehensive genomic datasets tailored to local health
56
MAFFT, a powerful tool for multiple sequence alignment, challenges. 67
has been widely used in infectious disease research, crop
genomics, and human genetics. For example, during The continued development and adoption of open-
the Ebola outbreak in West Africa, MAFFT was used to source bioinformatics tools and investments in digital
align viral sequences and track key mutations affecting infrastructure and training will be crucial for sustaining
43
transmissibility and virulence. In malaria research, their impact in Africa. Initiatives that provide access to
MAFFT has facilitated the study of genetic variations open-source software, hardware, and internet resources
linked to drug resistance, aiding in developing region- for low-resource institutions will amplify the benefits
specific treatment protocols. In addition, MAFFT has of bioinformatics. Collaborative networks, such as the
68
49
been used in crop genomics to identify drought-resistant African Bioinformatics Network, can play a pivotal role in
genes in maize and sorghum, contributing to agricultural fostering knowledge exchange and driving joint research
resilience in drought-prone regions. 42 efforts. 70
A key advantage of open-source tools is their African researchers are uniquely positioned to tackle
affordability, which is transformative for African countries region-specific health challenges. By leveraging open-
with limited research funding. By eliminating the high source bioinformatics tools, they can identify biomarkers
67

Volume 2 Issue 2 (2025) 59 doi: 10.36922/imo.8111